Tirz is a synthetic dual incretin analogue discussed around GLP-1 and GIP receptor pathways. It is a key reference for customers comparing single GLP-1 materials, dual incretin materials, and triple incretin materials.
The main research interest is receptor pairing. Tirz literature focuses on how GLP-1 and GIP receptor activity can be studied together in metabolic signalling, glucose-regulation marker models, satiety-signalling models, and receptor-selectivity work.
For product comparison, Tirz sits between Semaglutide, which is GLP-1 focused, and GLP-3, which adds glucagon receptor activity to the GLP-1/GIP discussion. The specification table covers the supplied sequence notation and analytical profile.
The references below are starting points for the mechanisms discussed here. The specification table on this page covers identity, formula, molecular mass, physical form, solubility, storage, and lot-level analytical information.
References
Research-use notice: Supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use.
